Consolidated Statements of Operations (Unaudited) (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Revenue	$ 11,862	$ 0
Operating expenses:
General and administrative (including stock-based compensation (Note 8))	6,874,573	6,347,302
Depreciation	905,871	15,809
Research and development (including stock-based compensation (Note 8))	191,709	161,541
Total operating expenses	7,972,153	6,524,652
Loss from operations	(7,960,291)	(6,524,652)
Other expense (income):
Interest expense	289,604	66,024
Gain on extinguishment of liabilities		(125,796)
	289,604	(59,772)
Net loss	(8,249,895)	(6,464,880)
Net loss attributable to the noncontrolling interest	6,134	17,036
Net loss attributable to Bion	(8,243,761)	(6,447,844)
Conversion inducement		(755,258)
Dividends on preferred stock	(4,417)	(155,175)
Net loss applicable to Bion's common stockholders	$ (8,248,178)	$ (7,358,277)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in Dollars per share)	$ (0.48)	$ (0.48)
Weighted-average number of common shares outstanding:
Basic and diluted (in Shares)	17,315,436	15,436,388